A5007164301- Blood Pressure and Hypertension Studies
- Cardiovascular Health and Disease Prevention
- Atrial Fibrillation Management and Outcomes
- Heart Rate Variability and Autonomic Control
- Cardiac Arrhythmias and Treatments
- Cardiac Imaging and Diagnostics
- Cardiac pacing and defibrillation studies
- Heart Failure Treatment and Management
- Acute Ischemic Stroke Management
- Cardiovascular Function and Risk Factors
- Acute Myocardial Infarction Research
- Cardiovascular Syncope and Autonomic Disorders
- Cardiac electrophysiology and arrhythmias
- Cerebrovascular and Carotid Artery Diseases
- Cardiomyopathy and Myosin Studies
- Venous Thromboembolism Diagnosis and Management
- Pharmaceutical Economics and Policy
- Cardiac Health and Mental Health
- Lipoproteins and Cardiovascular Health
- Cardiac tumors and thrombi
- Chemotherapy-induced cardiotoxicity and mitigation
- Antiplatelet Therapy and Cardiovascular Diseases
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Statistical Methods in Clinical Trials
- Healthcare Systems and Technology
Hospital de Sant Joan Despí Moisès Broggi
2016-2024
Universitat de Barcelona
2016-2023
Institut d'Investigació Biomédica de Bellvitge
2022-2023
Hospital Universitari de Vic
2023
Consorci Sanitari Garraf
2003-2018
Ajuntament de L’Hospitalet
2017
La Ligue Contre le Cancer
2016
Université Paris-Saclay
2016
Inserm
2016
Université de Versailles Saint-Quentin-en-Yvelines
2016
Background We aimed to estimate the prevalence of refractory hypertension (RfH) and determine clinical differences between these patients resistant hypertensives ( RH ). Secondly, we assessed white‐coat RfH true‐ patients. Methods Results The present analysis was conducted on Spanish Ambulatory Blood Pressure Monitoring Registry database containing 70 997 treated hypertensive were defined by presence elevated office blood pressure (≥140 and/or 90 mm Hg) in with at least 3 ) 5...
Background and aim: Central blood pressure (BP) is increasingly considered as a better estimator of hypertension associated risks. We aimed to evaluate the association 24-h central BP, in comparison with peripheral presence target organ damage (TOD). Methods: Cross-sectional study 208 hypertensive patients, aged 57 ± 12 years, 34% women. Office (mean 4 measurements) BP were measured by oscillometric Mobil-O-Graph device. TOD was assessed at cardiac (left ventricular hypertrophy...
We aimed to evaluate the association of aortic and brachial short‐term blood pressure variability (BPV) with presence target organ damage (TOD) in hypertensive patients. One‐hundred seventy‐eight patients, aged 57 ± 12 years, 33% women were studied. TOD was defined by left ventricular hypertrophy on echocardiogram, microalbuminuria, reduced glomerular filtration rate, or increased pulse wave velocity. Aortic BPV assessed 24‐hour ambulatory BP monitoring (Mobil‐O‐Graph). present 92 patients...
Central blood pressure (BP) is considered as a better estimator of hypertension-associated risks than peripheral BP. We aimed to evaluate the association 24-hour central BP, in comparison with presence left ventricular hypertrophy (LVH), or diastolic dysfunction (DD).The cross-sectional study consisted 208 hypertensive patients, aged 57 ± 12 years, which 34% were women. Office and BP measured by oscillometric Mobil-O-Graph device. performed echocardiography-Doppler measurements calculate LVH...
<b><i>Background/Aims:</i></b> Central blood pressure (BP) has been suggested to be a better estimator of hypertension-associated risks. We aimed evaluate the association 24-hour central BP, in comparison with peripheral presence renal organ damage hypertensive patients. <b><i>Methods:</i></b> Brachial and (calculated by an oscillometric system through brachial pulse wave analysis) office BP ambulatory monitoring (ABPM) data aortic velocity...
To analyze the temporal trends of atrial fibrillation (AF)-related ischemic stroke (IS) and their relationship with prescription patterns antithrombotic treatment from 2013 to 2019 in Health Assistance Area a regional hospital.First, retrospective ecological study aggregate data annual incidence IS between was performed. Second, we selected those patients diagnosed AF performed longitudinal assess role therapy development AF-related IS.During this period, whereas remained stable (from 1.3...
Background Myocardial dysfunction elicited during cholinergic coronary vasospasm is generally ascribed to myocardial ischemia. However, when pericoronary nerves extend the ventricles, efferent vagal discharges that elicit vasoconstriction may, at same time, depress contractility by releasing acetylcholine into myocardium. We analyzed whether a neurally mediated effect contributes impairment of ventricular function vasoconstriction. Methods and Results Left (LV) function, ECG mapping,...
To analyze the impact of implementing a program integrating cardiology and primary care in clinical practice.In integrated model, every cardiologist was assigned to each center.The implementation new model associated with significant reduction 31.2% requests first visits. In addition, delay consultation significantly decreased by 54.5% for visits, 57.1% follow-up The proportion patients that achieved recommended low density lipoprotein-cholesterol goals increased from 20.8 29.6%. submitted...
Introduction: Arterial stiffness may have a significant impact on the development of cerebral small vessel disease (cSVD). Patients and methods: We obtained pulse wave velocity (24-h PWV) by means ambulatory blood pressure monitoring (ABPM) in patients with recent subcortical infarct (RSSI). known cardiac or arterial embolic sources were excluded. Lacunes, microbleeds, white matter hyperintensities enlarged perivascular spaces at baseline assessed brain MRI included cSVD score. A follow-up...
Introduction and objectives: Conventional methods of Holter (H) monitoring, data analysis reporting can be inefficient, leading to high costs long response times. Traditional H devices cumbersome wear, uncomfortable testing reduce patient compliance satisfaction, impacting diagnostic performance. This new device ePatchTM is a simple application patch activation without the need charge battery connecting cables (Figure 1). Up 14 days continuous Electrocardiogram (ECG) recording. It worn in...